PA
IDXX icon

Procyon Advisors’s Idexx Laboratories IDXX Stock Holding History

Procyon Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
3,416
+120
+4% +$67.3K 0.08% 202
2026
Q1 		$1.85M Buy
3,296
+391
+13% +$251K 0.09% 199
2025
Q4 		$1.97M Buy
+2,905
New +$1.98M 0.1% 178
2025
Q2 		– Sell
-2,119
Closed -$890K – 542
2025
Q1 		$890K Buy
2,119
+709
+50% +$308K 0.05% 275
2024
Q4 		$583K Sell
1,410
-134
-9% -$58.8K 0.04% 304
2024
Q3 		$780K Buy
1,544
+33
+2% +$16K 0.05% 270
2024
Q2 		$736K Buy
1,511
+88
+6% +$44.2K 0.05% 262
2024
Q1 		$769K Buy
1,423
+11
+0.8% +$6.01K 0.06% 257
2023
Q4 		$784K Buy
1,412
+58
+4% +$27.2K 0.07% 241
2023
Q3 		$592K Buy
1,354
+399
+42% +$199K 0.06% 273
2023
Q2 		$480K Buy
+955
New +$458K 0.06% 282
2020
Q3 		– Sell
-3
Closed -$1K – 586
2020
Q2 		$1K Hold
3
– – ﹤0.01% 990
2020
Q1 		$1K Hold
3
– – ﹤0.01% 925
2019
Q4 		$1K Buy
+3
New +$791 ﹤0.01% 936

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Procyon Advisors's IDXX Position: Q2 2026 in Review

Procyon Advisors increased its Idexx Laboratories (IDXX) stake by 3.6% in Q2 2026, buying an estimated $67.3K and bringing the position to 3,416 shares worth $1.8M. The position accounts for 0.08% of the portfolio, ranked #202.

Procyon Advisors first reported a position in IDXX in Q4 2019 and has held it in 14 quarters since. The position peaked at $1.97M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Procyon Advisors held 3,416 shares of Idexx Laboratories worth $1.8M as of Q2 2026.
  • Procyon Advisors bought 120 Idexx Laboratories shares in Q2 2026, an estimated $67.3K.
  • Idexx Laboratories made up 0.08% of Procyon Advisors's portfolio in Q2 2026, its #202 holding.
  • Procyon Advisors first reported a position in Idexx Laboratories in Q4 2019 and has held it in 14 quarters since.
  • Procyon Advisors's Idexx Laboratories position peaked at $1.97M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.